Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

BACKGROUND: Several clinical trials reported that clopidogrel was superior to aspirin in secondary stroke prevention by reducing the risk of major adverse cardiovascular events (MACE). We aimed to compare the efficacy of clopidogrel with aspirin in reducing one-year risk of MACE based on real-world...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidyanti, Amelia Nur, Chan, Lung, Lin, Cheng-Li, Muo, Chih-Hsin, Hsu, Chung Y., Chen, You-Chia, Wu, Dean, Hu, Chaur-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715172/
https://www.ncbi.nlm.nih.gov/pubmed/31465467
http://dx.doi.org/10.1371/journal.pone.0221750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715172/
https://www.ncbi.nlm.nih.gov/pubmed/31465467
http://dx.doi.org/10.1371/journal.pone.0221750

Ejemplares similares